clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT02981368 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
phase III clinical trial | Q42824827 | ||
P17 | country | Canada | Q16 |
United States of America | Q30 | ||
P582 | end time | 2018-07-01 | |
P921 | main subject | medical diagnosis | Q177719 |
metastatic prostate carcinoma | Q55779807 | ||
P2899 | minimum age | 18 | |
P1132 | number of participants | 385 | |
P1813 | short name | OSPREY | |
P580 | start time | 2016-11-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients With PRostate Cancer: Examination of Diagnostic AccuracY (OSPREY) |